AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIROAerospace & Defense
+$0.43 today
- Market cap
- $141.13M
- Beta
- 1.82
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$0.56
Volume 0.28M
Average 0.62M
AIRO Other Financing Activities
Financing cash flows not reported separately.
AIRO Group Holdings, Inc. Common StockNASDAQ: AIRO
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities outflow grows to $0
Q1 FY2026 other financing activities was $0, compared with $0 a year earlier. Trailing-twelve-month other financing activities was -$13.01M. Over 3 fiscal years it compounded at +425.5% a year.
Context
- Other financing activities amounted to 14.5% of revenue in FY2025, down 4.7 pp from a year earlier.
- Other financing activities grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other financing activities holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$3.25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (13.18M) USD
- Year-over-year change
- +21.0%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (13.18M) | +21.0% |
| FY2024 | 2024-12-31 | (16.69M) | -81.2% |
| FY2023 | 2023-12-31 | (9.21M) | -10038.1% |
| FY2022 | 2022-12-31 | (90.85K) | -263.4% |
| FY2021 | 2021-12-31 | (25K) | — |
Other Financing Activities vs competitors
How AIRO compares with its peers on the latest reported figures
- Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
- Other financing activities amounts to 14.8% of revenue for AIRO, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $66.31M USD | +965.1% | — | 3.6% | |
| LTM Apr 2026 | $55.15M USD | +112.6% | — | 10.5% | |
| LTM Mar 2026 | $20.48M USD | +78680.8% | — | 27.9% | |
| LTM Mar 2026 | $13.01M USD | — | +425.5% | 14.8% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $10.84M USD | -9.1% | +98.1% | 4.3% |
| LTM Mar 2026 | $7.64M USD | +50.0% | — | 1.7% | |
| LTM Mar 2026 | £575.73K GBP | — | — | — | |
| LTM Feb 2026 | $306K USD | -378.2% | — | 0.3% | |
| LTM Mar 2026 | $192K USD | +92.0% | — | 0.0% | |
| LTM Feb 2026 | $44K USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding AIRO) | — | +92.0% | +98.1% | 1.7% | |
Competitors are the stored peer set for AIRO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (20.53M) | (25.55M) | (32.46M) | (38.69M) | (4.1M) |
| Depreciation & Amortization | 1.05M | 10.05M | 13.25M | 12.99M | 12.59M |
| Deferred Income Tax | 0 | (11.2M) | 974.75K | (653.88K) | 279K |
| Stock-Based Compensation | 3.99K | 2.85M | 1.82M | 716.09K | 19.91M |
| Change in Working Capital | 1.07M | 9.61M | 19.39M | (662.56K) | (27.9M) |
| Accounts Receivables | 251.84K | (25.35K) | 225.58K | (8.25M) | (1.9M) |
| Inventory | 230.66K | 2.81M | (663.52K) | (6.36M) | (1.71M) |
| Accounts Payables | 893.05K | 4.49M | 8.91M | 13.88M | (19.2M) |
| Other Working Capital | (302.51K) | 2.33M | 10.91M | 75.43K | (5.09M) |
| Other Non-Cash Items | 17.86M | 8.93M | 19.14M | 47.79M | (33.2M) |
| Operating Cash Flow | (535.06K) | (5.33M) | 22.11M | 21.49M | (32.43M) |
| Capital Expenditures | (39.04K) | (78.81K) | (835.92K) | (789.13K) | (3.07M) |
| Acquisitions (Net) | 0 | 873.26K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 129.2K | 0 | 0 | 0 |
| Investing Cash Flow | (39.04K) | 923.65K | (835.92K) | (789.13K) | (3.07M) |
| Debt Repayment | 530.2K | 4.55M | (77.69K) | 6.11M | (21.9M) |
| Common Stock Issued | 0 | 295.65K | 0 | 0 | 140.91M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (19.41M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (25K) | (90.85K) | (9.21M) | (16.69M) | (13.18M) |
| Financing Cash Flow | 505.2K | 4.75M | (9.29M) | (10.58M) | 86.41M |
| Effect of Forex Changes | 0 | 416.57K | 292.13K | (2.3M) | 2.73M |
| Net Change in Cash | (68.89K) | 765.03K | 12.27M | 7.81M | 53.64M |
| Free Cash Flow | (574.09K) | (5.41M) | 21.27M | 20.7M | (35.51M) |
AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIRO
Intrinsic Alpha fair value
Locked
Current Price
$4.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.